This information should be interpreted with a qualified healthcare provider to support a more nuanced conversation about which GLP-1 delivery method and formulation may align best with your genetic biology
Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1-31)NH(2)] in postmenopausal women with osteoporosis
Some vendors list nebulous batch numbers or fraudulent certificates of analysis
Contact your prescribing healthcare professional immediately, as they may recommend temporary dose reduction, additional anti-nausea medication, or alternative management strategies to help you through the adjustment period
A 2025 University of Virginia study concluded that while GLP-1 drugs significantly reduce body weight and adiposity, they do so "with no clear evidence of cardiorespiratory fitness enhancement"a critical finding given that cardiorespiratory fitness is among the most potent predictors of all-cause and cardiovascular mortality [48]
The results were announced today at the annual meeting of the American Diabetes Association and published in the New England Journal of Medicine